UNLABELLED: Point mutants of alpha1 -antitrypsin (α1AT) form ordered polymers that are retained as inclusions within the endoplasmic reticulum (ER) of hepatocytes in association with neonatal hepatitis, cirrhosis, and hepatocellular carcinoma. These inclusions cause cell damage and predispose to ER stress in the absence of the classical unfolded protein response (UPR). The pathophysiology underlying this ER stress was explored by generating cell models that conditionally express wild-type (WT) α1AT, two mutants that cause polymer-mediated inclusions and liver disease (E342K [the Z allele] and H334D) and a truncated mutant (Null Hong Kong; NHK) that induces classical ER stress and is removed by ER-associated degradation. Expression of the polymeric mutants resulted in gross changes in the ER luminal environment that recapitulated the changes observed in liver sections from individuals with PI*ZZ α1AT deficiency. In contrast, expression of NHK α1AT caused electron lucent dilatation and expansion of the ER throughout the cell. Photobleaching microscopy in live cells demonstrated a decrease in the mobility of soluble luminal proteins in cells that express E342K and H334D α1AT, when compared to those that express WT and NHK α1AT (0.34 ± 0.05, 0.22 ± 0.03, 2.83 ± 0.30, and 2.84 ± 0.55 μm(2) /s, respectively). There was no effect on protein mobility within ER membranes, indicating that cisternal connectivity was not disrupted. Polymer expression alone was insufficient to induce the UPR, but the resulting protein overload rendered cells hypersensitive to ER stress induced by either tunicamycin or glucose depletion. CONCLUSION: Changes in protein diffusion provide an explanation for the cellular consequences of ER protein overload in mutants that cause inclusion body formation and α1AT deficiency.
UNLABELLED: Point mutants of alpha1 -antitrypsin (α1AT) form ordered polymers that are retained as inclusions within the endoplasmic reticulum (ER) of hepatocytes in association with neonatal hepatitis, cirrhosis, and hepatocellular carcinoma. These inclusions cause cell damage and predispose to ER stress in the absence of the classical unfolded protein response (UPR). The pathophysiology underlying this ER stress was explored by generating cell models that conditionally express wild-type (WT) α1AT, two mutants that cause polymer-mediated inclusions and liver disease (E342K [the Z allele] and H334D) and a truncated mutant (Null Hong Kong; NHK) that induces classical ER stress and is removed by ER-associated degradation. Expression of the polymeric mutants resulted in gross changes in the ER luminal environment that recapitulated the changes observed in liver sections from individuals with PI*ZZ α1AT deficiency. In contrast, expression of NHK α1AT caused electron lucent dilatation and expansion of the ER throughout the cell. Photobleaching microscopy in live cells demonstrated a decrease in the mobility of soluble luminal proteins in cells that express E342K and H334D α1AT, when compared to those that express WT and NHK α1AT (0.34 ± 0.05, 0.22 ± 0.03, 2.83 ± 0.30, and 2.84 ± 0.55 μm(2) /s, respectively). There was no effect on protein mobility within ER membranes, indicating that cisternal connectivity was not disrupted. Polymer expression alone was insufficient to induce the UPR, but the resulting protein overload rendered cells hypersensitive to ER stress induced by either tunicamycin or glucose depletion. CONCLUSION: Changes in protein diffusion provide an explanation for the cellular consequences of ER protein overload in mutants that cause inclusion body formation and α1AT deficiency.
Authors: Tomás P Carroll; Catherine M Greene; Catherine A O'Connor; Aine M Nolan; Shane J O'Neill; Noel G McElvaney Journal: J Immunol Date: 2010-03-12 Impact factor: 5.422
Authors: Stefan J Marciniak; Chi Y Yun; Seiichi Oyadomari; Isabel Novoa; Yuhong Zhang; Rivka Jungreis; Kazuhiro Nagata; Heather P Harding; David Ron Journal: Genes Dev Date: 2004-12-15 Impact factor: 11.361
Authors: Heike Kroeger; Elena Miranda; Ian MacLeod; Juan Pérez; Damian C Crowther; Stefan J Marciniak; David A Lomas Journal: J Biol Chem Date: 2009-06-23 Impact factor: 5.157
Authors: James A Irving; Ugo I Ekeowa; Didier Belorgey; Imran Haq; Bibek Gooptu; Elena Miranda; Juan Pérez; Benoit D Roussel; Adriana Ordóñez; Lucy E Dalton; Sally E Thomas; Stefan J Marciniak; Helen Parfrey; Edwin R Chilvers; Jeffrey H Teckman; Sam Alam; Ravi Mahadeva; S Tamir Rashid; Ludovic Vallier; David A Lomas Journal: Methods Enzymol Date: 2011 Impact factor: 1.600
Authors: Shujuan Pan; Lu Huang; John McPherson; Donna Muzny; Farshid Rouhani; Mark Brantly; Richard Gibbs; Richard N Sifers Journal: Hepatology Date: 2009-07 Impact factor: 17.425
Authors: David A Lomas; James A Irving; Christopher Arico-Muendel; Svetlana Belyanskaya; Andrew Brewster; Murray Brown; Chun-Wa Chung; Hitesh Dave; Alexis Denis; Nerina Dodic; Anthony Dossang; Peter Eddershaw; Diana Klimaszewska; Imran Haq; Duncan S Holmes; Jonathan P Hutchinson; Alistair M Jagger; Toral Jakhria; Emilie Jigorel; John Liddle; Ken Lind; Stefan J Marciniak; Jeff Messer; Margaret Neu; Allison Olszewski; Adriana Ordonez; Riccardo Ronzoni; James Rowedder; Martin Rüdiger; Steve Skinner; Kathrine J Smith; Rebecca Terry; Lionel Trottet; Iain Uings; Steve Wilson; Zhengrong Zhu; Andrew C Pearce Journal: EMBO Mol Med Date: 2021-01-29 Impact factor: 12.137
Authors: Rhiannon B Werder; Joseph E Kaserman; Michael S Packer; Jonathan Lindstrom-Vautrin; Carlos Villacorta-Martin; Lauren E Young; Yvonne Aratyn-Schaus; Francine Gregoire; Andrew A Wilson Journal: Mol Ther Date: 2021-07-02 Impact factor: 12.910